Green Shield Canada

Prevention and management of muscle-related side effects

The process for reviewing and approving new cancer drugs in Canada takes almost twice as long as that in the United States and is longer than the approval times in Europe, concludes a new report from the public policy think tank Fraser Institute.

Members of Canada’s Olympic triathlon team – led by flag-bearer Simon Whitfield – have a leg up on their competitors, so to speak.

VANCOUVER _ Pediatric cancer patients are one step closer to being treated with new, less toxic and more precise drug therapies say scientists at the BC Cancer Agency's Michael Smith Genome Sciences Centre.

Myelofibrosis is a chronic, debilitating myeloproliferative disorder characterized by progressive anemia, bone marrow fibrosis, splenomegaly, and constitutional symptoms.

Problem results in failure of device to dispense dose of medication.

Research finds combination results in higher incidence of nonfatal strokes, renal complications, hyperkalemia, and hypotension.

Feraheme for anemia of chronic kidney disease; Toviaz for overactive bladder.